Atossa Genetics Inc (NASDAQ: ATOS) — Healthcare · Share Price, Chart & Market Data
About: Atossa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States. The company's lead drug candidate is oral (Z)-endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It also develops immunotherapy/chimeric antigen receptor therapy programs. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is based in Seattle, Washington.
Sector: Healthcare
Industry: Biotechnology
Latest price: $5.70 (-0.52%)
ATOSAtossa Genetics Inc
Loading watchlist status…
Trade ATOS now
Atossa Genetics Inc share price
ATOS price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 7:28 am GMT+0
ATOS price performance
-7.618%
5D
3.448%
1M
-39.74%
YTD
-48.13%
1Y
ATOS price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 7:28 am GMT+0
ATOS details
ATOS Market Signals